The same trend can also be seen for the subgroup of patients with AL-amyloidosis: lower CD38-expression is found with underlying asymptomatic myeloma compared to MGUS, being significant for GEP (p = 0.02) and flow cytometry (p = 0.008), respectively. This evidence concerns the gene CD38 and plasma cell myeloma.